Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Wendy Yarno

Wendy Yarno is recorded as Board Member at Tarsus Pharmaceuticals, Inc. (TARS). Iovance Biotherapeutics, Inc. reported in an 8-K filed March 20, 2026 that Wendy Yarno retired as member of the Board of Directors. Tarsus Pharmaceuticals, Inc. reported in an 8-K filed December 7, 2022 that Wendy Yarno was appointed Lead Independent Director, effective December 2, 2022.

“On March 17, 2026, Wendy Yarno, a member of the Board of Directors (the “Board”) of Iovance Biotherapeutics, Inc. (the “Company”), provided notice to the Board that she will retire from the Board and not be standing for re-election at the Company’s annual meeting of stockholders (the “Annual Meeting”) currently anticipated to be held in June 2026.”
Iovance Biotherapeutics, Inc. Form 8-K, filed March 20, 2026 · Read the filing
“the Board authorized and approved the appointment of Bobak Azamian, the Company's Chief Executive Officer and current member of the Board, as Chairperson of the Board, and Wendy Yarno, current member of the Board, as Lead Independent Director, each appointment effective as of December 2, 2022.”
Tarsus Pharmaceuticals, Inc. Form 8-K, filed December 7, 2022 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Tarsus Pharmaceuticals, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.